Access in all areas? A round-up of developments in market access and health technology assessment: part 11
Journal of Comparative Effectiveness Research · 2025
DOI: 10.57264/cer-2025-0176 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Comparative Effectiveness Research, 2025. Verfasst von Sreeram V Ramagopalan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Pharmaceutical Medicine Research, King's College London, SE1 9NH, UK. Hauptthemen laut MEDLINE: Technology Assessment, Biomedical, Insurance, Health, Health Services Accessibility, Insurance Coverage. Die Arbeit nennt 6 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
In this update, we cover the evolving health technology assessment process in Australia and also examine how commercial health plans in the US influence patient access to treatments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Centre for Pharmaceutical Medicine Research, King's College London, SE1 9NH, UK.
- ProductLife Group, 10 avenue de l'arche, 92400 Courbevoie, France.
- HEARS PTY Ltd, 506 Macarthur St, Soldiers Hill, Victoria 3350 Australia.
Zitieren
APA
Ramagopalan, S. V., Pannelay, A. J., & Atkins, J. (2025). Access in all areas? A round-up of developments in market access and health technology assessment: part 11. Journal of Comparative Effectiveness Research. https://doi.org/10.57264/cer-2025-0176
Vancouver
Ramagopalan SV, Pannelay AJ, Atkins J. Access in all areas? A round-up of developments in market access and health technology assessment: part 11. Journal of Comparative Effectiveness Research. 2025. doi:10.57264/cer-2025-0176
BibTeX
@article{Ramagopalan2025,
author = {Ramagopalan, Sreeram V and Pannelay, Annie Jullien and Atkins, Jo},
title = {Access in all areas? A round-up of developments in market access and health technology assessment: part 11},
journal = {Journal of Comparative Effectiveness Research},
year = {2025},
doi = {10.57264/cer-2025-0176}
}
EUVIMED